CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Sutro Biopharma, Inc. - STRO CFD

3.98
3.39%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 4.13
Open 4.05
1-Year Change -29.32%
Day's Range 3.98 - 4.16
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 10, 2024 4.12 -0.16 -3.74% 4.28 4.30 4.07
May 9, 2024 4.32 0.11 2.61% 4.21 4.47 4.15
May 8, 2024 4.25 -0.08 -1.85% 4.33 4.64 4.17
May 7, 2024 4.22 0.43 11.35% 3.79 4.22 3.79
May 6, 2024 3.87 0.03 0.78% 3.84 3.94 3.82
May 3, 2024 3.80 -0.18 -4.52% 3.98 4.08 3.79
May 2, 2024 3.92 0.21 5.66% 3.71 3.99 3.66
May 1, 2024 3.72 0.34 10.06% 3.38 3.77 3.36
Apr 30, 2024 3.37 -0.05 -1.46% 3.42 3.48 3.32
Apr 29, 2024 3.48 0.07 2.05% 3.41 3.65 3.40
Apr 26, 2024 3.40 0.02 0.59% 3.38 3.51 3.32
Apr 25, 2024 3.40 0.05 1.49% 3.35 3.44 3.28
Apr 24, 2024 3.45 -0.23 -6.25% 3.68 3.72 3.38
Apr 23, 2024 3.70 -0.05 -1.33% 3.75 3.91 3.68
Apr 22, 2024 3.74 0.11 3.03% 3.63 3.77 3.59
Apr 19, 2024 3.61 -0.08 -2.17% 3.69 3.78 3.53
Apr 18, 2024 3.73 -0.03 -0.80% 3.76 3.76 3.63
Apr 17, 2024 3.76 -0.12 -3.09% 3.88 4.01 3.76
Apr 16, 2024 3.92 -0.14 -3.45% 4.06 4.20 3.92
Apr 15, 2024 4.11 0.05 1.23% 4.06 4.22 4.02

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sutro Biopharma, Inc. Company profile

About Sutro Biopharma Inc

Sutro Biopharma, Inc. is a clinical stage drug discovery, development, and manufacturing company. It is focused on deploying its integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF, to create a variety of protein therapeutics, initially for cancer. It is engaged in designing therapeutics using potent modalities, including cytokine-based therapeutics, immuno-oncology agents, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed against clinically validated targets. Its product candidate includes STRO-002 and STRO-001. STRO-002, is an ADC directed against folate receptor-alpha, for patients with FolRα-expressing cancers, such as ovarian and endometrial cancers. STRO-001, is an ADC directed against CD74, for patients with B-cell malignancies, such as multiple myeloma and non-Hodgkin lymphoma. Its product candidates are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Sutro Biopharma Inc revenues increased 45% to $61.9M. Net loss increased from $32.1M to $105.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Unrealized (loss) gain on equity securit decrease from $41.5M (income) to $4.5M (expense), Research and development increase of 31% to $97.3M (expense).

Industry: Bio Therapeutic Drugs

111 Oyster Point Blvd.
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

Bank of England preview: possible rate cut in summer?

The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.

12:39, 8 May 2024

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

People also watch

BTC/USD

66,884.15 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,549.60 Price
+0.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,116.73 Price
+0.700% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.53 Price
-0.630% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading